Panjon Limited is an Indian-listed entity (BSE: **526345**) currently undergoing a significant strategic transformation. Historically rooted in real estate, the company has pivoted toward high-growth industrial sectors, including petroleum trading, bitumen manufacturing, and environmental services. Operating from its corporate hub in **Indore** and a production facility in the **Pithampur Industrial Area**, the company is aggressively restructuring its balance sheet to support this multi-sectoral expansion. --- ### **Strategic Pivot: Revenue Diversification & New Verticals** In response to stagnation in the legacy real estate market, Panjon has diversified into three primary industrial pillars: * **Petroleum & Bitumen Operations:** * **Petroleum Trading:** This has emerged as the primary driver of turnover, replacing real estate as the core revenue generator. * **Bitumen Emulsion:** As of **October 24, 2023**, the company commenced manufacturing operations at **Rasayani**, focusing on bitumen emulsion and specialized road construction materials. * **Environmental Services & Waste Management:** * The company has entered the specialized field of **medical bi-product management**. * Operations include the recycling of medical waste and the deployment of **biomedical waste machinery**. * **Brand & Intellectual Property Strategy:** * In **August 2023**, the company entered into a **trademark agreement** with the Promoter, Mr. Jay Kothari. The management is actively pursuing the **leasing of brands** to generate high-margin licensing revenue. * **Legacy Real Estate:** * While the company maintains its "Reality Development" segment, it currently generates **zero revenue** due to market price volatility and economic headwinds. --- ### **Financial Trajectory & Growth Metrics** Panjon has demonstrated an exponential increase in its scale of operations over the last three fiscal years, characterized by triple-digit turnover growth. | Metric (Figures in Rs. Hundred) | FY 2024-25 | FY 2023-24 | FY 2022-23 | | :--- | :--- | :--- | :--- | | **Total Turnover** | **30,45,801.47** | **1,25,520.73** | **64,737.00** | | **Profit Before Tax (PBT)** | **52,744.22** | **15,743.11** | **11,780.00** | | **Turnover Growth (YoY)** | **142.65%** | **93.89%** | — | | **PBT Growth (YoY)** | **235.00%** | **33.64%** | — | *Note: The Board has recommended **Nil Dividend** for FY 2023-24 and FY 2022-23, opting to reinvest 100% of profits into **Working Capital Requirements**.* --- ### **Capital Restructuring & Debt-to-Equity Strategy** A central component of Panjon’s strategy is the conversion of promoter debt into equity to improve its **Debt-Equity Ratio** and enhance creditworthiness with financial institutions. * **Authorized Capital Expansion:** Increased from **Rs. 15.50 Crore** to **Rs. 18.50 Crore** (Approved Sept 2023). * **Paid-Up Capital:** Currently stands at **Rs. 17,16,45,260** (comprising **1,71,64,526** shares at **Rs. 10** face value). * **Preferential Allotment:** The company issued **25,63,532 Convertible Warrants** at a price of **Rs. 15** (including a **Rs. 5 premium**). * **Promoter Debt Conversion:** **Rs. 1.24 Crore** in outstanding loans from Managing Director Jay Kothari was utilized for warrant subscription. In **June 2024**, **8,55,000 warrants** were converted into equity. * **Shareholding Shift:** Following these allotments, Promoter holding is projected to rise from **52.03%** to **58.84%**. --- ### **Operational Infrastructure & Resource Allocation** The company is directing its newly raised capital toward modernizing its operational backbone: * **Technology & Equipment:** Investments are earmarked for **customized software**, high-end computing hardware, and safety equipment. * **Associate Holdings:** Panjon holds a **40% stake (10,00,000 shares)** in **Raunaq Laboratories Ltd**, providing exposure to the pharmaceutical/lab sector. * **Asset Integrity:** The company maintains a rigorous **physical verification program** for all property, plant, and equipment, ensuring all title deeds are held directly in the company’s name. * **Human Capital:** Growth is contingent on the "right mix" of technical staff; funds are specifically allocated for the **hiring and training** of skilled manpower. --- ### **Risk Profile & Governance Challenges** Investors should note specific regulatory and market-based risks that impact the company’s valuation and operational stability. #### **1. Regulatory Compliance Lapses** * **Auditor Appointment Issue (2024-25):** The Board appointed **M/s. Goyal Parul & Co.** as Statutory Auditors without the mandatory shareholder approval required under **Section 139** of the Companies Act, 2013. * **Historical Penalties:** In **August 2022**, the company was fined **₹2,12,400** by the **BSE** for failing to maintain a **2/3rd majority** of Independent Directors in the Audit Committee. This led to a temporary **suspension of Promoter demat accounts**. #### **2. Market & Operational Headwinds** * **Margin Compression:** The company increasingly targets **Government Registered Companies** via **tender-based bidding**. As the "lowest bidder" model prevails, percentage profit margins are under constant pressure. * **Input Cost Sensitivity:** Profitability is highly sensitive to the fluctuating costs of **Diesel** and the availability of **Skilled/Unskilled manpower**. * **Macroeconomic Sensitivity:** The real estate and infrastructure segments are vulnerable to **interest rate hikes**, which dampen purchaser demand, and the general scarcity of land in India. --- ### **Corporate Governance Summary** The Board consists of **five Directors**, maintaining a balance between executive leadership and independent oversight. * **Key Leadership:** * **Jay Kothari:** Managing Director (Re-appointed through **August 2028**). * **Pramod Kumar Ajmera:** Chief Financial Officer. * **Arpita Vijay Vargiya:** Company Secretary & Compliance Officer. * **Board Composition:** Includes **two Executive Directors** and **three Non-Executive Independent Directors** (including one **Woman Independent Director**).